Anneke C Blackburn
Overview
Explore the profile of Anneke C Blackburn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang C, Blackburn A, Loh A, Hong K, Goh J, Hein N, et al.
Biomedicines
. 2023 May;
11(4).
PMID: 37189750
The survival rate of patients with osteosarcoma (OS) has not improved over the last 30 years. Mutations in the genes , and frequently occur in OS and enhance RNA Polymerase...
2.
Kang C, Hannan K, Blackburn A, Loh A, Hong K, Yuan G, et al.
Invest New Drugs
. 2022 Feb;
40(3):529-536.
PMID: 35201535
Background: Uterine leiomyosarcoma is a rare aggressive smooth muscle cancer with poor survival rates. RNA Polymerase I (Pol I) activity is elevated in many cancers supporting tumour growth and prior...
3.
Majhi P, Griner N, Mayfield J, Compton S, Kane J, Baptiste T, et al.
Oncogene
. 2021 Jun;
40(31):5026-5037.
PMID: 34183771
Breast cancer is the most common tumor among women with inherited variants in the TP53 tumor suppressor, but onset varies widely suggesting interactions with genetic or environmental factors. Rodent models...
4.
Lineweaver C, Bussey K, Blackburn A, Davies P
Bioessays
. 2021 May;
43(7):e2000305.
PMID: 33984158
It has long been recognized that cancer onset and progression represent a type of reversion to an ancestral quasi-unicellular phenotype. This general concept has been refined into the atavistic model...
5.
Yoon J, Parish C, Blackburn A, Coupland L
Platelets
. 2020 Jul;
32(5):662-670.
PMID: 32664767
The ability of platelets to promote carcinoma and melanoma progression has been thoroughly studied and occurs in numerous ways. In contrast, the effect of platelets on sarcomas, tumors arising from...
6.
Tian D, Bennett S, Coupland L, Forwood K, Lwin Y, Pooryousef N, et al.
Pharmacol Res Perspect
. 2019 Oct;
7(6):e00526.
PMID: 31624634
Dichloroacetate (DCA) is an investigational drug targeting the glycolytic hallmark of cancer by inhibiting pyruvate dehydrogenase kinases (PDK). It is metabolized by GSTZ1, which has common polymorphisms altering enzyme or...
7.
Ratnadiwakara M, Rooke M, Ohms S, French H, Williams R, Li R, et al.
J Steroid Biochem Mol Biol
. 2018 Dec;
188:48-58.
PMID: 30529760
Breast cancer is a complex disease, and approximately 30% of cases are considered to be hereditary or familial, with a large fraction of this being polygenic. However, it is difficult...
8.
Khan A, Andrews D, Shainhouse J, Blackburn A
World J Clin Oncol
. 2017 Aug;
8(4):371-377.
PMID: 28848705
Sodium dichloroacetate (DCA) has been studied as a metabolic cancer therapy since 2007, based on a publication from Bonnet et al demonstrating that DCA can induce apoptosis (programmed cell death)...
9.
Mishra A, Parish C, Wong M, Licinio J, Blackburn A
PLoS One
. 2017 May;
12(5):e0178454.
PMID: 28542577
Epidemiological studies have shown obesity to be linked with poorer outcomes in breast cancer patients. The molecular mechanisms responsible for the increased risk of invasive/metastatic disease with obesity are complex,...
10.
Khan A, Andrews D, Blackburn A
World J Clin Cases
. 2016 Nov;
4(10):336-343.
PMID: 27803917
Oral dichloroacetate sodium (DCA) has been investigated as a novel metabolic therapy for various cancers since 2007, based on data from Bonnet et al that DCA can trigger apoptosis of...